We apply the latest science to create, test, and scale solutions to address the most intractable problems in cancer care delivery.
Our Initiatives
We employ a health equity lens across our work, examining and addressing socioeconomic, racial, and ethnic disparities and other systemic barriers to accessing high quality, patient-centered healthcare.
In partnership with Gilead Sciences, a research team led by PC3I Faculty Lola Fayanju will focus on collection of social and behavioral determinants of health to improve health outcomes for patients with breast cancer.
As part of a study supported by the National Cancer Institute (NCI), investigators are identifying and testing communication methods to streamline the coordination of cervical cancer treatment and diagnosis.
Penn Medicine experts have conducted research providing new insights into telemedicine and its effectiveness in the rehabilitation setting to inform how to best use telemedicine to improve care for people with cancer.
The Guaranteed Income and Financial Treatment Trial (G.I.F.T.T.) pairs a financial navigation program with guaranteed monthly income and evaluates its impact on cancer-related financial hardship, currently experienced by one in three patients during the course of their treatment.
The University of Pennsylvania (Penn) Telehealth ReseArch Center of Excellence (Penn TRACE), based at the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center, is one of four NCI Telehealth Research Centers of Excellence dedicated to advancing the nation's telehealth research agenda focused on improving cancer-related care and outcomes, with support from the White House Cancer Moonshot.